The flu vaccine effectively prevents influenza in pregnant women, regardless of whether they are HIV positive, according to a new study. Results offer clinicians greater assurance to vaccinate all pregnant woman.
A once daily MVC plus DRV/r regimen had an effective role in antiretroviral drug-pretreated individuals with controlled HIV infection in this trial. In an aging HIV-infected population, with increasing comorbidities, this combination could be a safer option than standard triple therapy. More here.
It now seems probable that most people with HCV infection can be cured—even if they are co-infected with HIV. But can we bear the cost?
Antiretroviral treatment does not appear to affect a woman's ability to become pregnant or to adversely affect fetal outcomes, according to this study.
Here: a quiz about treating oral candidiasis with an azole drug in an HIV-positive person.
Preexposure Prophylaxis with Tenofovir or Emtricitabine-Tenofovir Reduces Herpes Simplex Virus Type -2 Transmission
This study demonstrates an added benefit to tenofovir-based preexposure prophylaxis regimens in preventing HSV-2.
A statistically significant association exists between efavirenz for initial HIV therapy and the risk suicidality. When this drug is given as a component of an antiretroviral drug regimen, patients should be monitored carefully for the possibility of deterioration of their depression or evidence of suicidal behavior.
Optimal timing for Starting Antiretroviral Therapy in HIV-Infected Patients with Cryptococcal Meningitis
Physicians who treat patients with cryptococcal meningitis in untreated AIDS patients should be aware that early initiation of antiretroviral therapy is associated with increased mortality.
New recommendations for HIV testing in laboratories will lead to HIV diagnosis as much as 3 to 4 weeks sooner, according to the CDC.
Finding a good doctor to manage HIV probably matters a lot, but finding a good doctor, or any useable or reliable information about a particular doctor, is almost impossible. Here: 5 tips on finding a good HIV physician.
Women of all races and ethnicities are less likely to take antiretroviral therapy than men. Consideration of both gender and race/ethnicity is thus needed to identify areas for targeted intervention to improve outcomes relevant to specific groups of women."
The tools exist to eliminate HIV, but non-adherence is common. New evidence suggests that triggered reminders can influence adherence rates in HIV-positive patients.
ART works wonders, but only when patients actively engage in sustained care.
HIV-positive patients have about double the usual risk of kidney disease. Here, detailed guidance on how to monitor for and manage it in this population.
CDC has finalized its guidelines on use of pre-exposure prophylaxis for HIV, which have been well-received and may ease some concerns. But the new public health strategy still faces hurdles.